About Enable Life Sciences
Enable Life Sciences is a company based in Cambridge (United States) founded in 2013 by Rachit Ohri. Enable Life Sciences offers products and services including Innovation Management Services and R&D Project Management. Enable Life Sciences operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Cambridge, United States
- Founders Rachit Ohri
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Enable Life Sciences Private Limited
- Date of Incorporation 01 Oct, 2013
- Jurisdiction Gurgaon, Haryana, India
-
Annual Revenue
Not available
-
Net Profit
-$802.59 (USD)-23.32as on Mar 31, 2020
-
EBITDA
-$318.11 (USD)51.12as on Mar 31, 2020
-
Latest Funding Round
$274.98 K (USD), Grant
Sep 15, 2023
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Enable Life Sciences
Enable Life Sciences offers a comprehensive portfolio of products and services, including Innovation Management Services and R&D Project Management.
Manages innovation processes for life sciences clients
Handles R&D projects in biotechnology and pharmaceuticals
Funding Insights of Enable Life Sciences
Investors in Enable Life Sciences
Enable Life Sciences has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for Enable Life Sciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Enable Life Sciences
Investment portfolio details for Enable Life Sciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Enable Life Sciences
Detailed financials for Enable Life Sciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Enable Life Sciences Comparisons
Peer comparison for Enable Life Sciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Enable Life Sciences
Enable Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
Detailed competitors of Enable Life Sciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Enable Life Sciences
Complete news archive for Enable Life Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Enable Life Sciences
Enable Life Sciences was founded in 2013 and raised its 1st funding round 7 years after it was founded.
Enable Life Sciences is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Rachit Ohri is the current CEO of Enable Life Sciences. They have also founded this company.
Enable Life Sciences was founded in 2013 and is based in Cambridge, United States. Operations focus on the biotechnology sector, where a range of services is offered, including management for research and development as well as manufacturing units, analytical support, medical device development, molecular biology, cell culture, and in vivo evaluation and analysis. The actimmunity assay, a cell culture-based tool, has also been developed by the company.
Enable Life Sciences's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Enable Life Sciences offers Innovation Management Services and R&D Project Management.
Enable Life Sciences has 1 investor. Key investors include HHS.